| [Bioinformatic analysis of CCND2 expression in papillary thyroid carcinoma and its impact on immune infiltration]. | [Bioinformatic analysis of CCND2 expression in papillary thyroid carcinoma and its impact on immune infiltration].
Wang Q, Song B, Hao S, Xiao Z, Jin L, Zheng T, Chai F., Free PMC Article | 06/21/2024 |
| Up-regulation of lncRNA WT1-AS ameliorates Abeta-stimulated neuronal injury through modulation of miR-186-5p/CCND2 axis in Alzheimer's disease. | Up-regulation of lncRNA WT1-AS ameliorates Aβ-stimulated neuronal injury through modulation of miR-186-5p/CCND2 axis in Alzheimer's disease.
Tang Y, Zhang X, Wang S, Liu L, Wang Q, Liu Y, Yu Y, Zhai Q. | 03/21/2024 |
| GABA regulates the proliferation and apoptosis of head and neck squamous cell carcinoma cells by promoting the expression of CCND2 and BCL2L1. | GABA regulates the proliferation and apoptosis of head and neck squamous cell carcinoma cells by promoting the expression of CCND2 and BCL2L1.
Luo K, Zhao X, Shan Y, Wang X, Xu Y, Chen M, Wang Q, Song Y. | 11/29/2023 |
| METTL3-mediated m[6]A modification of lncRNA SNHG3 accelerates gastric cancer progression by modulating miR-186-5p/cyclinD2 axis. | METTL3-mediated m(6)A modification of lncRNA SNHG3 accelerates gastric cancer progression by modulating miR-186-5p/cyclinD2 axis.
Ji G, Wang X, Xi H., Free PMC Article | 11/3/2023 |
| MiR-188-5p inhibits cell proliferation and migration in ovarian cancer via competing for CCND2 with ELAVL1. | MiR-188-5p inhibits cell proliferation and migration in ovarian cancer via competing for CCND2 with ELAVL1.
Zhang H, Yuan N, Che H, Cheng X. | 06/15/2023 |
| CCND2 and miR-206 as potential biomarkers in the clinical diagnosis of thyroid carcinoma by fine-needle aspiration cytology. | CCND2 and miR-206 as potential biomarkers in the clinical diagnosis of thyroid carcinoma by fine-needle aspiration cytology.
Yuan S, Liu Z, Yu S, Wang X, Shi J., Free PMC Article | 02/4/2023 |
| LncRNA RP11805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR34b3p and miR1395p in lung adenocarcinoma. | LncRNA RP11‑805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR‑34b‑3p and miR‑139‑5p in lung adenocarcinoma.
Zhu H, Xu X, Zheng E, Ni J, Jiang X, Yang M, Zhao G., Free PMC Article | 07/30/2022 |
| Interaction of CCND2, CDKN1A, and POLD3 Variants in Mexican Patients with Colorectal Cancer. | Interaction of CCND2, CDKN1A, and POLD3 Variants in Mexican Patients with Colorectal Cancer.
Alvizo-Rodríguez CR, Flores-López BA, Ayala-Madrigal ML, Partida-Pérez M, Macías-Gómez NM, Peregrina-Sandoval J, Suárez-Villanueva AS, Moreno-Ortiz JM, Cervantes-Ortiz S, Maciel-Gutiérre VM, Gutiérrez-Angulo M., Free PMC Article | 07/16/2022 |
| BAP18 induces growth of non-small-cell lung carcinoma through upregulating transcriptional level of CCND1/2. | BAP18 induces growth of non-small-cell lung carcinoma through upregulating transcriptional level of CCND1/2.
Wei SJ, Li J, Wang JY, Zhang LX, Zhang HB, Du DJ, Li QX. | 06/11/2022 |
| Long noncoding RNA FAM225B facilitates proliferation and metastasis of nasopharyngeal carcinoma cells by regulating miR-613/CCND2 axis. | Long noncoding RNA FAM225B facilitates proliferation and metastasis of nasopharyngeal carcinoma cells by regulating miR-613/CCND2 axis.
Dai W, Shi Y, Hu W, Xu C., Free PMC Article | 02/26/2022 |
| Expression of obesity- and type-2 diabetes-associated genes in omental adipose tissue of individuals with obesity. | Expression of obesity- and type-2 diabetes-associated genes in omental adipose tissue of individuals with obesity.
Molina-Ayala MA, Rodríguez-Amador V, Suárez-Sánchez R, León-Solís L, Gómez-Zamudio J, Mendoza-Zubieta V, Cruz M, Suárez-Sánchez F. | 02/12/2022 |
| CircTHBS1 targeting miR-211/CCND2 pathway to promote cell proliferation and migration potential in primary cystitis glandularis cells. | CircTHBS1 targeting miR-211/CCND2 pathway to promote cell proliferation and migration potential in primary cystitis glandularis cells.
Ma Y, Shan Z, Liu Y, Shao H, Xin Y, He K, Jiang S, Wang Y., Free PMC Article | 02/5/2022 |
| Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR17 to regulate cyclinD2 expression. | Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR‑17 to regulate cyclinD2 expression.
Yu B, Li M, Han SP, Yu Z, Zhu J., Free PMC Article | 02/5/2022 |
| Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes. | Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.
Pirozzi F, Lee B, Horsley N, Burkardt DD, Dobyns WB, Graham JM Jr, Dentici ML, Cesario C, Schallner J, Porrmann J, Di Donato N, Sanchez-Lara PA, Mirzaa GM., Free PMC Article | 01/22/2022 |
| Hypermethylation of Cyclin D2 Predicts Poor Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma after Hepatectomy. | Hypermethylation of Cyclin D2 Predicts Poor Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma after Hepatectomy.
Qian Y, Wang H, Zhang Y, Wang JW, Fan YC, Gao S, Wang K. | 01/22/2022 |
| Reduced expression of microRNA-432-5p by DNA methyltransferase 3B leads to development of colorectal cancer through upregulation of CCND2. | Reduced expression of microRNA-432-5p by DNA methyltransferase 3B leads to development of colorectal cancer through upregulation of CCND2.
Yun Z, Yue M, Kang Z, Zhang P. | 01/15/2022 |
| CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma. | CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma.
Richardson TE, Walker JM. | 12/18/2021 |
| Decreased ERbeta expression and high cyclin D1 expression may predict early CRC recurrence in high-risk Duke's B and Duke's C stage. | Decreased ERβ expression and high cyclin D1 expression may predict early CRC recurrence in high-risk Duke's B and Duke's C stage.
Babic A, Miladinovic N, Milin Lazovic J, Milenkovic S. | 12/18/2021 |
| Downregulation of miR-892b inhibits the progression of osteoarthritis via targeting cyclin D1 and cyclin D2. | Downregulation of miR-892b inhibits the progression of osteoarthritis via targeting cyclin D1 and cyclin D2.
Zhao J, Zhang Z, Zuo T, Yu J, Yang S, Yang Y, Li X, Zheng J. | 10/16/2021 |
| Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma. | Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.
Alvarez-Benayas J, Trasanidis N, Katsarou A, Ponnusamy K, Chaidos A, May PC, Xiao X, Bua M, Atta M, Roberts IAG, Auner HW, Hatjiharissi E, Papaioannou M, Caputo VS, Sudbery IM, Karadimitris A., Free PMC Article | 10/16/2021 |
| miR-451a suppresses the development of breast cancer via targeted inhibition of CCND2. | miR-451a suppresses the development of breast cancer via targeted inhibition of CCND2.
Zhang H, Chen P, Yang J. | 08/28/2021 |
| Medulloblastoma in the setting of megalencephaly polymicrogyria polydactyly hydrocephalus. | Medulloblastoma in the setting of megalencephaly polymicrogyria polydactyly hydrocephalus.
Hadzipasic M, Karsten MB, Olson H, Rodan L, Lidov H, Prabhu SP, Wright K, Fehnel KP. | 08/14/2021 |
| CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients. | CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients.
Cassinat B, Verger E, Maslah N, Gauthier N, Vainchenker W, Giraudier S, Kiladjian JJ., Free PMC Article | 07/10/2021 |
| Identification of CXCL13/CXCR5 axis's crucial and complex effect in human lung adenocarcinoma. | Identification of CXCL13/CXCR5 axis's crucial and complex effect in human lung adenocarcinoma.
Tian C, Li C, Zeng Y, Liang J, Yang Q, Gu F, Hu Y, Liu L. | 06/26/2021 |
| Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2. | Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2.
Bouchart C, Trépant AL, Hein M, Van Gestel D, Demetter P., Free PMC Article | 05/1/2021 |